Company Profile
Sinotherapeutics Inc., a specialty pharmaceutical company, research develops, manufactures, and commercializes generic and formulation products in China. The company's products are indicated for infection, oncology and rheumatology, gastroenterology and metabolism, neurology, cardiology, and nephrology. It offers posaconazole delayed-release tablets.
Its portfolio also includes olaparib, exemestane, and tofacitinib extended-release tablets, and mesalamine delayed-release, dapagliflozin and metformin hydrochloride sustained-release, sitagliptin and metformin hydrochloride sustained-release tablets, and ursodeoxycholic ACID Capsules bupropion hydrochloride extended-release tablets, and paroxetine and pregabalin extended-release tablets.
Its portfolio also includes propafenone hydrochloride extended-release capsules, and sevelamer carbonate tablets. Founded in 2012, Sinotherapeutics is headquartered in Shanghai, China.